Recombinant Equine TNF-alpha Protein Summary
Product Specifications
Leu78-Leu234, with an N-terminal Met
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
1814-ET
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 25 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
1814-ET/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: TNF-alpha
Tumor necrosis factor alpha (TNF-alpha ), also known as cachectin and TNFSF2, is the prototypic ligand of the TNF superfamily. It is a pleiotropic molecule that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism (1, 2). Equine TNF-alpha consisits of a 35 amino acid (aa) cytoplasmic domain, a 21 aa transmembrane segment, and a 178 aa extracellular domain (ECD) (3). Within the ECD, equine TNF-alpha shares 69% - 88% aa sequence identity with bovine, canine, cotton rat, feline, human, mouse, porcine, rat, and rhesus TNF-alpha. TNF-alpha is produced by a wide variety of immune, epithelial, endothelial, and tumor cells (1, 2). TNF-alpha is assembled intracellularly to form a noncovalently linked homotrimer which is expressed on the cell surface (4). Cell surface TNF-alpha can induce the lysis of neighboring tumor cells and virus infected cells, and it can generate its own downstream cell signaling following ligation by soluble TNFR I (2, 5). Shedding of membrane bound TNF-alpha by TACE/ADAM17 releases the bioactive cytokine, a 55 kDa soluble trimer of the TNF-alpha extracellular domain (6-8). TNF-alpha binds the ubiquitous 55-60 kDa TNF RI (9, 10) and the hematopoietic cell-restricted 80 kDa TNF RII (11, 12), both of which are also expressed as homotrimers (1, 2, 13). Both type I and type II receptors bind TNF-alpha with comparable affinity (14), although only TNF RI contains a cytoplasmic death domain which triggers the activation of apoptosis. Soluble forms of both types of receptors are released and can neutralize the biological activity of TNF-alpha (15).
- Zelova, H. and J. Hosek (2013) Inflamm. Res. 62:641.
- Juhasz, K. et al. (2013) Expert Rev. Clin. Immunol. 9:335.
- Su, X.Z. et al. (1991) Gene 107:319.
- Tang, P. et al. (1996) Biochemistry 35:8216.
- Perez, C. et al. (1990) Cell 63:251.
- Black, R.A. et al. (1997) Nature 385:729.
- Moss, M.L. et al. (1997) Nature 385:733.
- Gearing, A.J.H. et al. (1994) Nature 370:555.
- Schall, T.J. et al. (1990) Cell 61:361.
- Loetscher, H. et al. (1990) Cell 61:351.
- Dembic, Z. et al. (1990) Cytokine 2:231.
- Smith, C.A. et al. (1990) Science 248:1019.
- Loetscher, H. et al. (1991) J. Biol. Chem. 266:18324.
- Pinckard, J.K. et al. (1997) J. Biol. Chem. 272:10784.
- Engelmann, H. et al. (1990) J. Biol. Chem. 265:1531.
Citations for Recombinant Equine TNF-alpha Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
8
Citations: Showing 1 - 8
Filter your results:
Filter by:
-
Equine Arteritis Virus in Monocytic Cells Suppresses Differentiation and Function of Dendritic Cells
Authors: NA Moyo, D Westcott, R Simmonds, F Steinbach
Viruses, 2023-01-16;15(1):.
Species: Equine
Sample Types: Whole Cells
Applications: Bioassay -
Equine keratinocytes in the pathogenesis of insect bite hypersensitivity: Just another brick in the wall?
Authors: I Cvitas, S Oberhaensl, T Leeb, E Marti
PLoS ONE, 2022-08-01;17(8):e0266263.
Species: Equine
Sample Types: Whole Cells
Applications: Bioassay -
Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines
Authors: B Jeremiasse, C Matta, CR Fellows, DJ Boocock, JR Smith, S Liddell, F Lafeber, WE van Spil, A Mobasheri
BMC Mol Cell Biol, 2020-06-26;21(1):47.
Species: Equine
Sample Types: Whole Cells
Applications: Bioassay -
Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells
Authors: A Lange-Cons, P Romele, M Magatti, A Silini, A Idda, NA Martino, F Cremonesi, O Parolini
Stem Cell Res Ther, 2020-03-04;11(1):99.
Species: Equine
Sample Types: Whole Cells
Applications: Cell Culture -
Effects of Orally Administered Resveratrol on TNF, IL-1beta, Leukocyte Phagocytic Activity and Oxidative Burst Function in Horses: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study
Authors: LM Martin, PJ Johnson, JR Amorim, AE DeClue
Int J Mol Sci, 2020-02-20;21(4):.
Species: N/A
Sample Types: N/A
Applications: Reference Standard -
Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility
Authors: L Barrachina, A Cequier, A Romero, A Vitoria, P Zaragoza, FJ Vázquez, C Rodellar
Stem Cell Res Ther, 2020-02-07;11(1):52.
Species: Equine
Sample Types: Whole Cells
Applications: Cell Culture -
Effects of priming with cytokines on intracellular survival and replication of Rhodococcus equi in equine macrophages
Authors: LJ Berghaus, S Giguère, AI Bordin, ND Cohen
Cytokine, 2017-12-12;102(0):7-11.
Species: Equine
Sample Types: Whole Cells
Applications: Bioassay -
IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells.
Authors: Huang H, Lavoie-Lamoureux A, Moran K, Lavoie JP
Am. J. Physiol. Lung Cell Mol. Physiol., 2007-05-01;292(5):L1147-54.
Species: Equine
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Equine TNF-alpha Protein
There are currently no reviews for this product. Be the first to review Recombinant Equine TNF-alpha Protein and earn rewards!
Have you used Recombinant Equine TNF-alpha Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image